Home

The Korea Herald

Latest news

Most Popular

  1. 1

    Contentious grain bill put directly to plenary meeting for vote

    Contentious grain bill put directly to plenary meeting for vote
  2. 2

    Yoon's approval rating plunges to all-time low

    Yoon's approval rating plunges to all-time low
  3. 3

    Will tug-of-war between doctors, government end soon?

    Will tug-of-war between doctors, government end soon?
  4. 4

    Climate impacts set to cut 2050 global GDP by nearly a fifth

    Climate impacts set to cut 2050 global GDP by nearly a fifth
  5. 5

    Trilateral talks acknowledge ‘serious’ slumps of won, yen

    Trilateral talks acknowledge ‘serious’ slumps of won, yen
  1. 6

    [Graphic News] More Koreans say they plan long-distance trips this year

    [Graphic News] More Koreans say they plan long-distance trips this year
  2. 7

    [KH Explains] Hyundai's full hybrid edge to pay off amid slow transition to pure EVs

    [KH Explains] Hyundai's full hybrid edge to pay off amid slow transition to pure EVs
  3. 8

    North Korea removes streetlights along cross-border roads with South

    North Korea removes streetlights along cross-border roads with South
  4. 9

    Russia's denial of entry of S. Korean national unrelated to bilateral ties: Seoul official

    Russia's denial of entry of S. Korean national unrelated to bilateral ties: Seoul official
  5. 10

    Farming households dip below 1m for first time in 2023

    Farming households dip below 1m for first time in 2023
피터빈트

Korea Ginseng teams up with International Vaccine Institute to develop immune booster

By Yim Hyun-su

Published : Dec. 4, 2020 - 15:06

    • Link copied

Dr. Jerome Kim, director general of the International Vaccine Institute (left), and Korea Ginseng CEO Kim Jae-su pose at a signing event Thursday. (Korea Ginseng) Dr. Jerome Kim, director general of the International Vaccine Institute (left), and Korea Ginseng CEO Kim Jae-su pose at a signing event Thursday. (Korea Ginseng)
South Korea’s leading ginseng manufacturer, Korea Ginseng, has signed a memorandum of understanding with the International Vaccine Institute to develop an adjuvant -- an agent that can improve the performance of a vaccine.

The two will work together to develop an adjuvant using Korea Ginseng’s popular red ginseng brand CheongKwanJang, the company said Friday.

Korea Ginseng will provide 12 types of ginsenosides while the institute, a nonprofit organization that is working with vaccine companies to develop COVID-19 vaccines, will conduct research into their effectiveness as an immune booster.

The company added that findings from the research could help vaccine development.

Dr. Song Man-ki, the institute’s acting deputy director general of science, said the new research is part of many efforts to develop an adjuvant for various vaccines including ones against COVID-19.

Park Chae-kyu, head of Korea Ginseng’s research and development unit, said he expects the newly signed memorandum to increase the value of red ginseng.

By Yim Hyun-su (hyunsu@heraldcorp.com)

More from Headlines